A natural single-guide RNA repurposes Cas9 to autoregulate CRISPR-Cas expression.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33421369.
- Also identified by DOI 10.1016/j.cell.2020.12.017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
CRISPR-Cas systems provide prokaryotes with acquired immunity against viruses and plasmids, but how these systems are regulated to prevent autoimmunity is poorly understood. Here, we show that in the S. pyogenes CRISPR-Cas system, a long-form transactivating CRISPR RNA (tracr-L) folds into a natural single guide that directs Cas9 to transcriptionally repress its own promoter (P<sub>cas</sub>). Further, we demonstrate that P<sub>cas</sub> serves as a critical regulatory node. De-repression causes a dramatic 3,000-fold increase in immunization rates against viruses; however, heightened immunity comes at the cost of increased autoimmune toxicity. Using bioinformatic analyses, we provide evidence that tracrRNA-mediated autoregulation is widespread in type II-A CRISPR-Cas systems. Collectively, we unveil a new paradigm for the intrinsic regulation of CRISPR-Cas systems by natural single guides, which may facilitate the frequent horizontal transfer of these systems into new hosts that have not yet evolved their own regulatory strategies.
Medical subject headings
- CRISPR-Associated Protein 9
- CRISPR-Cas Systems
- Gene Expression
- Homeostasis
- RNA, Guide, CRISPR-Cas Systems